ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

10.06 (USD) • At close July 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Revenue 000000
Cost of Revenue 1.0320.9660.8970.9710
Gross Profit -1.032-0.966-0.897-0.97-10
Gross Profit Ratio 000000
Reseach & Development Expenses 85.17261.6856.85835.92122.84419.026
General & Administrative Expenses 25.60825.08722.01313.4225.7253.345
Selling & Marketing Expenses -1.03200000
SG&A 24.57625.08722.01313.4225.7253.345
Other Expenses 050.0150.1770.2890.233
Operating Expenses 109.74886.76778.87149.34328.56922.371
Operating Income -110.78-91.767-78.871-74.186-28.569-22.371
Operating Income Ratio 000000
Total Other Income Expenses Net 10.0832.6450.1560.4831.6860.233
Income Before Tax -100.697-89.122-78.715-73.703-26.883-21.363
Income Before Tax Ratio 000000
Income Tax Expense 02.355-1.03823.567-1.397-1.008
Net Income -100.697-91.477-77.677-97.27-25.486-21.363
Net Income Ratio 000000
EPS -1.96-2.31-2.05-4.43-0.85-1.12
EPS Diluted -1.96-2.31-2.05-4.43-0.85-1.12
EBITDA -109.748-81.767-78.871-24.5-27.541-21.468
EBITDA Ratio 000000